BioNTech says has supplied more than 1 billion COVID-19 vaccine doses so far
- Pfizer late last month raised its forecast for its share of 2021 vaccine sales to $33.5 billion
- That includes sales, milestone payments from partners and a share of gross profit in its partners' territories, the company added